Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Taisho Toyama to Unify Compensation, Promotion Systems for MRs
February 28, 2005
- 1st 3 Qtrs Business Results -1-
February 28, 2005
- Nippon Chemiphar Aims to Double GE Sales by FY2007
February 28, 2005
- 1st 3 Qtrs Business Results -2-
February 28, 2005
- Sawai Announces Revised 3-year Management Plan
February 28, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 28, 2005
- MREAC to Begin Improving Education, Training System
February 28, 2005
- BULLETIN
February 28, 2005
- Fujisawa to Transfer Marketing of 11 Products to 3 Companies
February 28, 2005
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
February 28, 2005
- Daiichi Suntory Transfer Sales of Farom to Maruho
February 28, 2005
- Meet the Leaders (40)
February 28, 2005
- BUSINESS NEWS IN BRIEF
February 28, 2005
- Sunrise Plan Aims at Sales of \360 Billion in 2010: Mr Nagayama of Chugai
February 28, 2005
- OTC NEWS IN BRIEF
February 21, 2005
- Kringle, Galeni Make Research Evaluation Accord
February 21, 2005
- FPMAJ's GL on Handling of Personal Information Announced
February 21, 2005
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
February 21, 2005
- JPEC to Start GMP Compliance Certification for Pharm. Excipients
February 21, 2005
- DIAGNOSTIC NEWS IN BRIEF
February 21, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…